Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. | Chief Accounting Officer | Stock Option (right to buy) | 110K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Chief Accounting Officer |
DSGN | Design Therapeutics, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Chief Accounting Officer |
DSGN | Design Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Accounting Officer |
DSGN | Design Therapeutics, Inc. | Oct 1, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Chief Accounting Officer |
DSGN | Design Therapeutics, Inc. | Sep 13, 2021 | 0 | $0 | 3 | Sep 20, 2021 | Chief Accounting Officer |